| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.
|
Atherosclerosis
|
2002
|
1.16
|
|
2
|
The roles of cells and cytokines in the pathogenesis of psoriasis.
|
Int J Dermatol
|
2012
|
1.14
|
|
3
|
Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy.
|
Eur J Obstet Gynecol Reprod Biol
|
2005
|
1.13
|
|
4
|
The effect of green tea in oxidative stress.
|
Clin Nutr
|
2006
|
1.03
|
|
5
|
Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood.
|
J Pregnancy
|
2012
|
1.02
|
|
6
|
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
|
Acta Haematol
|
2009
|
0.99
|
|
7
|
Neutrophil activation and C-reactive protein concentration in preeclampsia.
|
Hypertens Pregnancy
|
2003
|
0.99
|
|
8
|
LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study.
|
Atherosclerosis
|
2004
|
0.98
|
|
9
|
Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
|
J Clin Immunol
|
2008
|
0.97
|
|
10
|
Anti-inflammatory activity of chitooligosaccharides in vivo.
|
Mar Drugs
|
2010
|
0.94
|
|
11
|
Leukocyte Count versus C-Reactive Protein Levels in Obese Portuguese Patients Aged 6-12 Years Old.
|
Open Biochem J
|
2010
|
0.91
|
|
12
|
Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
|
Am J Nephrol
|
2008
|
0.89
|
|
13
|
Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
|
Hemodial Int
|
2010
|
0.88
|
|
14
|
Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels.
|
Arch Pediatr Adolesc Med
|
2009
|
0.88
|
|
15
|
Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients.
|
Br J Haematol
|
2010
|
0.87
|
|
16
|
Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis.
|
Blood Cells Mol Dis
|
2008
|
0.87
|
|
17
|
Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria.
|
BJOG
|
2002
|
0.86
|
|
18
|
Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients.
|
Ren Fail
|
2013
|
0.86
|
|
19
|
The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus.
|
J Investig Med
|
2014
|
0.86
|
|
20
|
Type of vascular access and location in online hemodiafiltration and its association with patient's perception of health-related quality of life.
|
J Vasc Access
|
2013
|
0.86
|
|
21
|
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
|
Am J Nephrol
|
2008
|
0.85
|
|
22
|
Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping.
|
Cardiovasc Toxicol
|
2009
|
0.85
|
|
23
|
Fetal lipoprotein changes in pre-eclampsia.
|
Acta Obstet Gynecol Scand
|
2008
|
0.85
|
|
24
|
Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications.
|
Open Biochem J
|
2012
|
0.85
|
|
25
|
Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index.
|
Am J Med Sci
|
2012
|
0.83
|
|
26
|
Effects of olive oil polyphenols on erythrocyte oxidative damage.
|
Mol Nutr Food Res
|
2009
|
0.83
|
|
27
|
Effects of chitooligosaccharides on human red blood cell morphology and membrane protein structure.
|
Biomacromolecules
|
2008
|
0.83
|
|
28
|
Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
|
Ren Fail
|
2011
|
0.83
|
|
29
|
Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.
|
Blood Cells Mol Dis
|
2012
|
0.83
|
|
30
|
Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies.
|
Eur J Obstet Gynecol Reprod Biol
|
2004
|
0.82
|
|
31
|
Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients.
|
Blood Cells Mol Dis
|
2010
|
0.82
|
|
32
|
Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration.
|
Qual Life Res
|
2014
|
0.82
|
|
33
|
Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses.
|
Hemodial Int
|
2013
|
0.82
|
|
34
|
Band 3 as a marker of erythrocyte changes in pregnancy.
|
Eur J Haematol
|
2002
|
0.81
|
|
35
|
Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
|
Growth Factors
|
2009
|
0.81
|
|
36
|
Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
|
Thromb Res
|
2008
|
0.81
|
|
37
|
Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease.
|
J Dermatol Sci
|
2009
|
0.80
|
|
38
|
Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
|
Hemodial Int
|
2012
|
0.80
|
|
39
|
Biocompatibility and hemocompatibility of polyvinyl alcohol hydrogel used for vascular grafting--In vitro and in vivo studies.
|
J Biomed Mater Res A
|
2014
|
0.80
|
|
40
|
Changes in red blood cells membrane protein composition during hemodialysis procedure.
|
Ren Fail
|
2008
|
0.79
|
|
41
|
Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes.
|
Int J Biol Macromol
|
2011
|
0.79
|
|
42
|
Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.
|
Mar Drugs
|
2012
|
0.79
|
|
43
|
Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage.
|
J Perinat Med
|
2009
|
0.79
|
|
44
|
Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
|
Ren Fail
|
2010
|
0.79
|
|
45
|
Impact of a School-Based Intervention Protocol - ACORDA Project - On Adipokines in An Overweight and Obese Pediatric Population.
|
Pediatr Exerc Sci
|
2016
|
0.78
|
|
46
|
Lipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia.
|
Atherosclerosis
|
2002
|
0.78
|
|
47
|
Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size.
|
Atherosclerosis
|
2005
|
0.78
|
|
48
|
Health-related quality of life in Portuguese psoriatic patients: relation with Psoriasis Area and Severity Index and different types of classical psoriatic treatment.
|
J Dermatol
|
2010
|
0.78
|
|
49
|
Main determinants of PON1 activity in hemodialysis patients.
|
Am J Nephrol
|
2012
|
0.78
|
|
50
|
Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: potential mechanisms of hepatotoxicity.
|
Toxicology
|
2013
|
0.78
|
|
51
|
DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis.
|
Acta Haematol
|
2008
|
0.77
|
|
52
|
Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
|
Am J Clin Dermatol
|
2010
|
0.77
|
|
53
|
Powerful protective role of 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde against erythrocyte oxidative-induced hemolysis.
|
J Agric Food Chem
|
2010
|
0.77
|
|
54
|
Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy.
|
Blood Purif
|
2008
|
0.77
|
|
55
|
Comparison of Bio-Plex measurements with standard techniques.
|
Clin Chem Lab Med
|
2011
|
0.76
|
|
56
|
Celiac disease diagnosis and gluten-free food analytical control.
|
Anal Bioanal Chem
|
2010
|
0.76
|
|
57
|
Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.
|
Basic Clin Pharmacol Toxicol
|
2013
|
0.76
|
|
58
|
Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region--a comparison of the bilirubin plasmatic levels in the different clinical forms.
|
Blood Cells Mol Dis
|
2010
|
0.76
|
|
59
|
Major determinants of BMP-2 serum levels in hemodialysis patients.
|
Ren Fail
|
2012
|
0.76
|
|
60
|
Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
|
Am J Clin Dermatol
|
2012
|
0.76
|
|
61
|
Protective activity of hydroxytyrosol metabolites on erythrocyte oxidative-induced hemolysis.
|
J Agric Food Chem
|
2013
|
0.75
|
|
62
|
Similarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise?
|
Curr Med Chem
|
2008
|
0.75
|
|
63
|
Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis.
|
Scand J Urol Nephrol
|
2012
|
0.75
|
|
64
|
IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy.
|
Blood Cells Mol Dis
|
2008
|
0.75
|
|
65
|
Bilirubin levels and redox status in a young healthy population.
|
Acta Haematol
|
2013
|
0.75
|
|
66
|
Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients.
|
J Vasc Access
|
2013
|
0.75
|
|
67
|
Evaluation of chitoligosaccharides effect upon probiotic bacteria.
|
Int J Biol Macromol
|
2011
|
0.75
|
|
68
|
Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A.
|
Int J Dermatol
|
2013
|
0.75
|
|
69
|
Elastase release during the hemodialysis procedure seems to induce changes in red blood cell membrane proteins.
|
Hemodial Int
|
2011
|
0.75
|
|
70
|
Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris.
|
Int J Dermatol
|
2012
|
0.75
|
|
71
|
Electroanalytical study of fluvoxamine.
|
Anal Bioanal Chem
|
2005
|
0.75
|
|
72
|
The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.
|
J Bioenerg Biomembr
|
2013
|
0.75
|
|
73
|
Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress.
|
Blood Cells Mol Dis
|
2009
|
0.75
|
|
74
|
Lipoprotein(a) levels in obese Portuguese children and adolescents: contribution of the pentanucleotide repeat (TTTTA)n polymorphism in the apolipoprotein(a) gene.
|
Arch Pediatr Adolesc Med
|
2009
|
0.75
|
|
75
|
Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome.
|
Clin Biochem
|
2011
|
0.75
|
|
76
|
Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
|
Am J Clin Dermatol
|
2013
|
0.75
|
|
77
|
High-density lipoprotein particles may regulate hemostasis in human pregnancy.
|
Fertil Steril
|
2005
|
0.75
|
|
78
|
Factors associated with the length of remission of psoriasis vulgaris.
|
Clin Drug Investig
|
2013
|
0.75
|